Our Pricing

Understanding Mounjaro Pen Pricing and Availability in the UK

If you're searching for the Mounjaro pen lowest price UK, Cured Pharmacy offers genuine UK-licensed tirzepatide injections from £135.00 with transparent upfront pricing and a free clinical consultation completed in under three minutes. Our UK-registered prescribers assess your suitability, and if approved, your medication is dispensed discreetly to your door with no hidden fees.

How Mounjaro (Tirzepatide) Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike single-pathway treatments such as semaglutide, tirzepatide activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, resulting in enhanced appetite suppression, improved insulin sensitivity, and reduced caloric intake [1].

In the landmark SURPASS-3 trial, participants receiving the 15 mg dose of tirzepatide achieved an average body weight reduction of 22.5% over 72 weeks, significantly outperforming comparator treatments [1]. The dual-agonist mechanism also contributes to improvements in glycaemic control and cardiovascular risk markers, making Mounjaro a comprehensive option for patients with obesity or type 2 diabetes [2].

Tirzepatide is administered once weekly via a pre-filled KwikPen, which simplifies dosing and improves adherence compared to daily injectable therapies. Patients typically begin on a lower dose and titrate upwards under prescriber guidance to minimise gastrointestinal side effects whilst optimising efficacy [3].

Mounjaro Pen Lowest Price UK: What Affects the Cost?

The cost of Mounjaro in the UK varies based on the prescribed dose strength, the duration of treatment, and the pharmacy dispensing it. At Cured Pharmacy, transparent pricing starts from £135.00, with no consultation fees or hidden charges added at checkout. Your final price depends on the dose your UK prescriber determines is clinically appropriate after your free online assessment.

Mounjaro is available in five dose strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, and 12.5 mg or 15 mg maintenance doses. Most patients begin at the lowest dose and gradually increase every four weeks, which means your monthly cost may change as your treatment progresses. Our pricing remains competitive across all dose tiers, and we guarantee the lowest prices in the UK market.

Unlike some online providers, Cured Pharmacy displays the cost before you complete your consultation, ensuring full transparency. There are no subscription lock-ins or mandatory repeat orders—you control your treatment timeline and can pause or adjust as needed, subject to prescriber approval.

Why Prices Vary Between UK Pharmacies

Price differences across UK pharmacies reflect variations in sourcing agreements, dispensing fees, and service models. Some providers bundle consultation fees separately, whilst others include them in the medication price. At Cured Pharmacy, our superintendent pharmacist Tarun Kumar (GPhC 2233073) has negotiated direct supply agreements to keep costs low without compromising on quality or regulatory compliance.

All Mounjaro pens dispensed by Cured Pharmacy are genuine UK-licensed products sourced from MHRA-approved wholesalers. We never supply unlicensed imports or compounded alternatives, ensuring every patient receives the same pharmaceutical-grade tirzepatide used in clinical trials.

Comparing Mounjaro to Other Weight Loss Injections

Mounjaro, Wegovy, and Saxenda are the three main injectable weight loss treatments licensed in the UK, each with distinct mechanisms and clinical profiles. Wegovy contains semaglutide, a GLP-1 receptor agonist that achieved an average weight loss of 14.9% over 68 weeks in the STEP-1 trial [4]. Saxenda uses liraglutide, an earlier-generation GLP-1 analogue administered daily, with average weight reductions of approximately 8% in clinical studies [5].

Tirzepatide's dual-agonist action produces superior weight loss outcomes compared to semaglutide in head-to-head trials, with fewer patients discontinuing treatment due to side effects [1][4]. However, individual response varies, and some patients may find single-pathway GLP-1 treatments more suitable based on their medical history, tolerance, and prescriber recommendation.

Cost is another consideration. Whilst Mounjaro offers the most robust efficacy data, it carries a higher price point than some alternatives. Wegovy and Saxenda may be more accessible starting options for patients new to injectable therapies or those with budget constraints. Your UK prescriber will discuss all licensed options during your consultation to identify the most appropriate treatment for your circumstances.

How to Buy Mounjaro Online Safely in the UK

Purchasing prescription medications online requires careful attention to pharmacy credentials and regulatory compliance. Cured Pharmacy is registered with the General Pharmaceutical Council (GPhC Registration Number 9012511), ensuring we meet all UK standards for dispensing, storage, and patient safety. Our clinical team includes UK-registered prescribers who conduct thorough assessments before approving any prescription.

To order Mounjaro through Cured Pharmacy, you'll complete a brief online consultation covering your medical history, current medications, weight loss goals, and any contraindications. This typically takes under three minutes and is reviewed by a UK prescriber within hours. If approved, your prescription is sent electronically to our dispensing team, and your medication is dispatched in discreet, unmarked packaging with tracked delivery.

Never purchase Mounjaro from unregistered websites, social media sellers, or overseas suppliers offering 'prescription-free' sales. These sources may supply counterfeit, expired, or improperly stored products that pose serious health risks. Always verify a pharmacy's GPhC registration before placing an order, and ensure a qualified prescriber reviews your suitability.

What to Expect During Your Online Consultation

Our online consultation asks targeted questions about your BMI, previous weight loss attempts, medical conditions such as thyroid disorders or pancreatitis, and any medications you currently take. This information allows the prescriber to assess whether Mounjaro is safe and appropriate for you, or whether an alternative treatment may be better suited.

If your consultation reveals contraindications—such as a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2—the prescriber will decline the prescription and suggest alternative approaches. This safeguarding process is a legal requirement and protects patient welfare above commercial considerations.

Common Side Effects and How to Manage Them

The most frequently reported side effects of Mounjaro are gastrointestinal, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort [1][3]. These effects are most pronounced during the initial weeks of treatment and typically diminish as your body adjusts to the medication. Starting at the lowest dose and titrating gradually helps minimise these symptoms.

To reduce nausea, patients are advised to eat smaller, more frequent meals, avoid high-fat or spicy foods, and stay well-hydrated. Ginger tea, plain crackers, and avoiding lying down immediately after eating can also provide relief. If nausea persists or worsens, contact your prescriber—they may adjust your dose or recommend an anti-emetic.

Rare but serious side effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other diabetes medications). Seek immediate medical attention if you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction such as facial swelling or difficulty breathing [3]. Your prescriber will monitor your progress through follow-up consultations to ensure the treatment remains safe and effective.

Who Can Use Mounjaro and Who Should Avoid It

Mounjaro is licensed in the UK for adults with a BMI of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea [6]. It is not approved for cosmetic weight loss in individuals with a healthy BMI, and prescribers will decline requests that fall outside clinical guidelines.

Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, and pregnancy or breastfeeding [3]. Patients with a history of pancreatitis, diabetic retinopathy, or renal impairment require careful assessment and may need alternative treatments or closer monitoring.

Mounjaro is not suitable for individuals under 18 years of age, as safety and efficacy data in paediatric populations are limited. Older adults may use Mounjaro, but prescribers will consider age-related factors such as kidney function and polypharmacy when determining suitability. Always disclose your full medical history during the consultation to ensure safe prescribing.

Lifestyle Factors That Support Treatment Success

Mounjaro is most effective when combined with a reduced-calorie diet and increased physical activity. Clinical trials enrolled patients who received nutritional counselling and exercise guidance alongside medication, and real-world outcomes are optimised through similar behavioural support [1][6].

Setting realistic goals—such as losing 5-10% of your starting weight over six months—improves adherence and reduces the risk of disappointment. Our clinical team can signpost you to NHS-approved weight management programmes and resources that complement your pharmacological treatment, ensuring a comprehensive approach to long-term health.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Bunck, M. C. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-218. https://doi.org/10.1056/NEJMoa2206038
2. Ludvik, B., Giorgino, F., Jódar, E., Frias, J. P., Fernández Landó, L., Brown, K., ... & Buse, J. B. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583-598. https://doi.org/10.1016/S0140-6736(21)01443-4
3. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/14298
4. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(11), 11-22. https://doi.org/10.1056/NEJMoa1411892
6. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating type 2 diabetes. NICE Technology Appraisal Guidance [TA924]. Retrieved from https://www.nice.org.uk/guidance/ta924

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and lifestyle factors.